ArticlePlant cell reports2026
Genome-wide identification of MYC transcription factors in Chrysanthemum morifolium and CmMYC25 promotes petal anthocyanin accumulation.
Article in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
key messageGenome-wide analysis coupled with spatiotemporal profiling identified CmMYC25 as a key regulator. It functions as a transcriptional co-activator to synergistically enhance CmMYB6-mediated anthocyanin biosynthesis in chrysanthemum petals. Myelocytomatosis (MYC) transcription factors (TFs), belonging to the basic helix-loop-helix (bHLH) superfamily, play a crucial role in regulating various physiological processes in plants. However, research on the MYC gene family in Chrysanthemum morifolium, one of the primary cut flowers, remains scarce. Here, we identified 28 CmMYC genes via genome-wide analysis and classified them into three subfamilies based on phylogenetic relationships. Collinearity analysis suggested expansion driven by both ancient whole-genome duplication (WGD) events and recent segmental duplications. Promoter analysis uncovered a variety of regulatory elements, with hormone-responsive motifs being the most predominant. Phylogenetic clustering indicated that Group B members are orthologous to anthocyanin regulators. Among them, CmMYC25 was prioritized for further analysis, as its expression pattern was perfectly synchronized with anthocyanin accumulation during flower development. CmMYC25 was localized to the nucleus but lacked transcriptional activation activity. Notably, yeast one-hybrid assays indicated that CmMYC25 does not directly bind to the promoters of anthocyanin biosynthetic genes. Instead, it physically interacts with CmMYB6, a central activator of anthocyanin biosynthesis. Dual-luciferase assays confirmed that CmMYC25 functions as a co-activator, synergistically enhancing the transcriptional activity of CmMYB6 on downstream target genes. Functional characterization verified that CmMYC25 acts as a positive regulator of floral pigmentation, as its overexpression significantly increased anthocyanin accumulation, while suppression reduced pigmentation. These findings provide insights into the evolution of CmMYC genes and elucidate the co-activator mechanism of CmMYC25 in regulating flower pigmentation.
Indexed as
Identifiers
41546707What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.